Crohns sjukdom (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Crohns sjukdom" in Swedish language version.

refsWebsite

Global rank Swedish rank

14nih.gov

4^th place

17^th place

10doi.org

2^nd place

14^th place

5worldcat.org

5^th place

9^th place

1web.archive.org

1^st place

1sciencedirect.com

149^th place

211^th place

1nejm.org

2,374^th place

1,630^th place

doi.org

dx.doi.org

Baumgart DC, Sandborn WJ (2012). ”Crohn's disease”. The Lancet 380 (9853): sid. 1590–605. doi:10.1016/S0140-6736(12)60026-9. PMID 22914295.
Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hugot JP, de Vos M, Vermeire S, Louis E, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwilliam R, Tremelling M, Deloukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ (2008). ”Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease”. Nature Genetics 40 (8): sid. 955–62. doi:10.1038/ng.175. PMID 18587394.
Casanova JL, Abel L (Aug 31, 2009). ”Revisiting Crohn's disease as a primary immunodeficiency of macrophages.”. The Journal of experimental medicine 206 (9): sid. 1839–43. doi:10.1084/jem.20091683. PMID 19687225.
Cosnes J (2004). ”Tobacco and IBD: Relevance in the understanding of disease mechanisms and clinical practice”. Best Practice & Research Clinical Gastroenterology 18 (3): sid. 481–96. doi:10.1016/j.bpg.2003.12.003. PMID 15157822.
Trikudanathan, Guru; Venkatesh, Preethi G. K.; Navaneethan, Udayakumar (24 december 2012). ”Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease”. Drugs 72 (18): sid. 2333–2349. doi:10.2165/11638120-000000000-00000. ISSN 1179-1950. PMID 23181971. Läst 17 mars 2019.
Lankarani, Kamran B; Sivandzadeh, Gholam Reza; Hassanpour, Shima (14 december 2013). ”Oral manifestation in inflammatory bowel disease: A review”. World Journal of Gastroenterology : WJG 19 (46): sid. 8571–8579. doi:10.3748/wjg.v19.i46.8571. ISSN 1007-9327. PMID 24379574. PMC: 3870502. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870502/. Läst 17 mars 2019.
”Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial” (på engelska). The Lancet 359 (9317): sid. 1541–1549. 2002-05-04. doi:10.1016/S0140-6736(02)08512-4. ISSN 0140-6736. https://www.sciencedirect.com/science/article/abs/pii/S0140673602085124. Läst 7 januari 2021.
Colombel, Jean Frédéric; Sandborn, William J.; Reinisch, Walter; Mantzaris, Gerassimos J.; Kornbluth, Asher; Rachmilewitz, Daniel (2010-04-15). ”Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease”. New England Journal of Medicine 362 (15): sid. 1383–1395. doi:10.1056/NEJMoa0904492. ISSN 0028-4793. PMID 20393175. https://doi.org/10.1056/NEJMoa0904492. Läst 7 januari 2021.
Baert, Filip; Noman, Maja; Vermeire, Severine; Van Assche, Gert; D' Haens, Geert; Carbonez, An (2003-02-13). ”Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease” (på engelska). New England Journal of Medicine 348 (7): sid. 601–608. doi:10.1056/NEJMoa020888. ISSN 0028-4793. http://www.nejm.org/doi/abs/10.1056/NEJMoa020888. Läst 7 januari 2021.

doi.org

Colombel, Jean Frédéric; Sandborn, William J.; Reinisch, Walter; Mantzaris, Gerassimos J.; Kornbluth, Asher; Rachmilewitz, Daniel (2010-04-15). ”Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease”. New England Journal of Medicine 362 (15): sid. 1383–1395. doi:10.1056/NEJMoa0904492. ISSN 0028-4793. PMID 20393175. https://doi.org/10.1056/NEJMoa0904492. Läst 7 januari 2021.

nejm.org

Baert, Filip; Noman, Maja; Vermeire, Severine; Van Assche, Gert; D' Haens, Geert; Carbonez, An (2003-02-13). ”Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease” (på engelska). New England Journal of Medicine 348 (7): sid. 601–608. doi:10.1056/NEJMoa020888. ISSN 0028-4793. http://www.nejm.org/doi/abs/10.1056/NEJMoa020888. Läst 7 januari 2021.

nih.gov

ncbi.nlm.nih.gov

Baumgart DC, Sandborn WJ (2012). ”Crohn's disease”. The Lancet 380 (9853): sid. 1590–605. doi:10.1016/S0140-6736(12)60026-9. PMID 22914295.
Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hugot JP, de Vos M, Vermeire S, Louis E, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwilliam R, Tremelling M, Deloukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ (2008). ”Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease”. Nature Genetics 40 (8): sid. 955–62. doi:10.1038/ng.175. PMID 18587394.
Casanova JL, Abel L (Aug 31, 2009). ”Revisiting Crohn's disease as a primary immunodeficiency of macrophages.”. The Journal of experimental medicine 206 (9): sid. 1839–43. doi:10.1084/jem.20091683. PMID 19687225.
Cosnes J (2004). ”Tobacco and IBD: Relevance in the understanding of disease mechanisms and clinical practice”. Best Practice & Research Clinical Gastroenterology 18 (3): sid. 481–96. doi:10.1016/j.bpg.2003.12.003. PMID 15157822.
Trikudanathan, Guru; Venkatesh, Preethi G. K.; Navaneethan, Udayakumar (24 december 2012). ”Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease”. Drugs 72 (18): sid. 2333–2349. doi:10.2165/11638120-000000000-00000. ISSN 1179-1950. PMID 23181971. Läst 17 mars 2019.
Lankarani, Kamran B; Sivandzadeh, Gholam Reza; Hassanpour, Shima (14 december 2013). ”Oral manifestation in inflammatory bowel disease: A review”. World Journal of Gastroenterology : WJG 19 (46): sid. 8571–8579. doi:10.3748/wjg.v19.i46.8571. ISSN 1007-9327. PMID 24379574. PMC: 3870502. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870502/. Läst 17 mars 2019.
Colombel, Jean Frédéric; Sandborn, William J.; Reinisch, Walter; Mantzaris, Gerassimos J.; Kornbluth, Asher; Rachmilewitz, Daniel (2010-04-15). ”Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease”. New England Journal of Medicine 362 (15): sid. 1383–1395. doi:10.1056/NEJMoa0904492. ISSN 0028-4793. PMID 20393175. https://doi.org/10.1056/NEJMoa0904492. Läst 7 januari 2021.
Molodecky, NA; Soon, IS; Rabi, DM; Ghali, WA; Ferris, M; Chernoff, G; Benchimol, EI; Panaccione, R; et al. (Jan 2012). ”Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.”. Gastroenterology 142 (1): sid. 46-54.e42; quiz e30. PMID 22001864.
Prideaux, L; Kamm, MA; De Cruz, PP; Chan, FK; Ng, SC (Aug 2012). ”Inflammatory bowel disease in Asia: a systematic review.”. Journal of gastroenterology and hepatology 27 (8): sid. 1266-80. PMID 22497584.
Hovde, Ø; Moum, BA (Apr 21, 2012). ”Epidemiology and clinical course of Crohn's disease: results from observational studies.”. World journal of gastroenterology : WJG 18 (15): sid. 1723-31. PMID 22553396.
Burisch, J; Munkholm, P (Jul 2013). ”Inflammatory bowel disease epidemiology.”. Current opinion in gastroenterology 29 (4): sid. 357-62. PMID 23695429.
Lozano, R; Naghavi, M (Dec 15, 2012). ”Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.”. Lancet 380 (9859): sid. 2095-128. PMID 23245604.
Crohn BB, Ginzburg L, Oppenheimer GD (2000). ”Regional ileitis: A pathologic and clinical entity. 1932”. The Mount Sinai journal of medicine, New York 67 (3): sid. 263–8. PMID 10828911.

digestive.niddk.nih.gov

”Crohn's Disease”. National Digestive Diseases Information Clearinghouse (NDDIC). July 10, 2013. Arkiverad från originalet den 9 juni 2014. https://web.archive.org/web/20140609002323/http://digestive.niddk.nih.gov/ddISeases/pubs/crohns/. Läst 12 juni 2014.

sciencedirect.com

”Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial” (på engelska). The Lancet 359 (9317): sid. 1541–1549. 2002-05-04. doi:10.1016/S0140-6736(02)08512-4. ISSN 0140-6736. https://www.sciencedirect.com/science/article/abs/pii/S0140673602085124. Läst 7 januari 2021.

web.archive.org

”Crohn's Disease”. National Digestive Diseases Information Clearinghouse (NDDIC). July 10, 2013. Arkiverad från originalet den 9 juni 2014. https://web.archive.org/web/20140609002323/http://digestive.niddk.nih.gov/ddISeases/pubs/crohns/. Läst 12 juni 2014.

worldcat.org

Trikudanathan, Guru; Venkatesh, Preethi G. K.; Navaneethan, Udayakumar (24 december 2012). ”Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease”. Drugs 72 (18): sid. 2333–2349. doi:10.2165/11638120-000000000-00000. ISSN 1179-1950. PMID 23181971. Läst 17 mars 2019.
Lankarani, Kamran B; Sivandzadeh, Gholam Reza; Hassanpour, Shima (14 december 2013). ”Oral manifestation in inflammatory bowel disease: A review”. World Journal of Gastroenterology : WJG 19 (46): sid. 8571–8579. doi:10.3748/wjg.v19.i46.8571. ISSN 1007-9327. PMID 24379574. PMC: 3870502. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870502/. Läst 17 mars 2019.
”Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial” (på engelska). The Lancet 359 (9317): sid. 1541–1549. 2002-05-04. doi:10.1016/S0140-6736(02)08512-4. ISSN 0140-6736. https://www.sciencedirect.com/science/article/abs/pii/S0140673602085124. Läst 7 januari 2021.
Colombel, Jean Frédéric; Sandborn, William J.; Reinisch, Walter; Mantzaris, Gerassimos J.; Kornbluth, Asher; Rachmilewitz, Daniel (2010-04-15). ”Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease”. New England Journal of Medicine 362 (15): sid. 1383–1395. doi:10.1056/NEJMoa0904492. ISSN 0028-4793. PMID 20393175. https://doi.org/10.1056/NEJMoa0904492. Läst 7 januari 2021.
Baert, Filip; Noman, Maja; Vermeire, Severine; Van Assche, Gert; D' Haens, Geert; Carbonez, An (2003-02-13). ”Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease” (på engelska). New England Journal of Medicine 348 (7): sid. 601–608. doi:10.1056/NEJMoa020888. ISSN 0028-4793. http://www.nejm.org/doi/abs/10.1056/NEJMoa020888. Läst 7 januari 2021.